0
     

Report Added
Report already added
Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027

Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027

The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%. The growth of this market can largely be attributed to the rising demand for bariatric surgeries, increasing number of surgeries, and rising prevalence of gastrointestinal diseases.

“The gastrointestinal surgery segment is expected to register the highest CAGR during the forecast period”
Based on application, the global endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The gastrointestinal surgery segment is expected to register the highest growth during the forecast period. This is mainly due to the growing number of gastrointestinal cancer cases worldwide.

“The ambulatory care centers segment to witness the highest growth in the endoluminal suturing devices end user market during the forecast period”
Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The ambulatory care centers segment is expected to register the highest growth during the forecast period. This can be attributed to the increased adoption of getting treated in ambulatory care settings due to the cost-effective treatment offered.

“The APAC to witness the highest growth during the forecast period.”
Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022–2027. The presence of high-growth markets such as India, China, and Japan, rapidly developing healthcare industry in China and India, increasing number of hospitals, rising per capita income, increasing healthcare infrastructure, rising burden of GI cancer, and the rising awareness about health are some of the major factors that are expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
•By Designation – C-level–35%, Director-level–25%, Others–40%
•By Region – North America–40%, Europe–30%, Asia Pacific–20%, Latin America- 5%, Middle East and Africa–5%

Key players in the Endoluminal suturing devices market
The prominent players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

Research Coverage:
The report analyzes the endoluminal suturing devices market and aims at estimating the market size and future growth potential of this market based on various segments such as, application, and end user. The report also includes a product portfolio matrix of various endoluminal suturing devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the endoluminal suturing devices market. The report analyzes this market by application and by end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoluminal suturing devices market.
•Market Development: Comprehensive information on the lucrative emerging markets by application and by end user.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoluminal suturing devices market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoluminal suturing devices market.

Table of Content

1INTRODUCTION20
1.1STUDY OBJECTIVES20
1.2MARKET DEFINITION20
1.2.1INCLUSIONS & EXCLUSIONS20
1.2.2MARKETS COVERED21
FIGURE 1ENDOLUMINAL SUTURING DEVICES MARKET SEGMENTATION21
1.2.3YEARS CONSIDERED21
1.3CURRENCY CONSIDERED22
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD22
1.4STAKEHOLDERS22
2RESEARCH METHODOLOGY23
2.1RESEARCH APPROACH23
2.2RESEARCH DESIGN23
FIGURE 2ENDOLUMINAL SUTURING DEVICES MARKET: RESEARCH DESIGN23
2.2.1SECONDARY RESEARCH24
2.2.1.1Key data from secondary sources25
2.2.2PRIMARY DATA25
FIGURE 3PRIMARY SOURCES26
2.2.2.1Key data from primary sources27
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION27
2.3MARKET SIZE ESTIMATION28
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS28
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION29
FIGURE 7TOP-DOWN APPROACH29
FIGURE 8CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES30
FIGURE 9CAGR PROJECTIONS31
2.4DATA TRIANGULATION APPROACH32
FIGURE 10DATA TRIANGULATION METHODOLOGY32
2.5MARKET SHARE ESTIMATION33
2.6ASSUMPTIONS33
2.7LIMITATIONS33
2.7.1METHODOLOGY-RELATED LIMITATIONS33
2.7.2SCOPE-RELATED LIMITATIONS34
2.8RISK ASSESSMENT34
TABLE 2RISK ASSESSMENT: ENDOLUMINAL SUTURING DEVICES MARKET34

3EXECUTIVE SUMMARY35
FIGURE 11ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)35
FIGURE 12ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)36
FIGURE 13GEOGRAPHIC SNAPSHOT OF ENDOLUMINAL SUTURING DEVICES MARKET37
4PREMIUM INSIGHTS38
4.1ENDOLUMINAL SUTURING DEVICES MARKET OVERVIEW38
FIGURE 14RISING NUMBER OF SURGICAL PROCEDURES PERFORMED TO DRIVE GROWTH38
4.2ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION AND COUNTRY (2021)39
FIGURE 15GASTROINTESTINAL SURGERIES ACCOUNTED FOR LARGEST SHARE
OF ASIA PACIFIC MARKET IN 202139
4.3ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES40
FIGURE 16CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD40
4.4ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION (2020–2027)41
FIGURE 17NORTH AMERICA TO DOMINATE ENDOLUMINAL SUTURING DEVICES MARKET IN 202741
5MARKET OVERVIEW42
5.1INTRODUCTION42
5.2MARKET DYNAMICS42
FIGURE 18ENDOLUMINAL SUTURING DEVICES MARKET: KEY DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES42
5.2.1DRIVERS43
5.2.1.1Increasing number of surgical procedures worldwide43
TABLE 3NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 202043
5.2.1.2Rising prevalence of gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases44
TABLE 4GLOBAL INCIDENCE OF COLORECTAL CANCER, 202045
TABLE 5GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 202045
5.2.1.3Favorable reimbursement scenario45
5.2.2RESTRAINTS46
5.2.2.1Presence of alternative wound care management products46
5.2.3OPPORTUNITIES46
5.2.3.1High-growth opportunities in emerging markets46
TABLE 6AVERAGE SURGICAL PROCEDURE COSTS (2021)46
5.2.3.2Increasing adoption of outpatient surgeries47
5.2.4CHALLENGES47
5.2.4.1Shortage of skilled personnel47

5.3REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS48
TABLE 7LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS48
5.4REGULATORY ANALYSIS49
5.4.1NORTH AMERICA49
5.4.1.1US49
TABLE 8US FDA: MEDICAL DEVICE CLASSIFICATION49
TABLE 9US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS50
5.4.1.2Canada50
TABLE 10CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS50
5.4.2EUROPE50
5.4.3ASIA PACIFIC51
5.4.3.1Japan51
TABLE 11JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA51
5.4.3.2China51
TABLE 12CHINA: CLASSIFICATION OF MEDICAL DEVICES52
5.4.3.3India52
5.5PORTER’S FIVE FORCES ANALYSIS52
TABLE 13PORTER’S FIVE FORCES ANALYSIS52
5.5.1THREAT FROM NEW ENTRANTS53
5.5.2THREAT FROM SUBSTITUTES53
5.5.3BARGAINING POWER OF SUPPLIERS53
5.5.4BARGAINING POWER OF BUYERS54
5.5.5INTENSITY OF COMPETITIVE RIVALRY54
5.6VALUE CHAIN ANALYSIS54
FIGURE 19VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE55
5.7INDUSTRY TRENDS55
5.7.1MINIMALLY INVASIVE SURGERY55
5.8TECHNOLOGY ANALYSIS56
5.8.1ROBOTIC SUTURING SYSTEMS56
5.9ECOSYSTEM ANALYSIS56
FIGURE 20SURGICAL SUTURES MARKET: ECOSYSTEM MAP (2021)56
5.10PATENT ANALYSIS57
5.10.1PATENT PUBLICATION TRENDS FOR ENDOLUMINAL SUTURING DEVICES57
FIGURE 21PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2022)57
5.10.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS57
FIGURE 22TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ENDOLUMINAL SUTURING DEVICES (JANUARY 2011–JULY 2022)58
FIGURE 23TOP APPLICANT JURISDICTIONS FOR ENDOLUMINAL SUTURING DEVICE PATENTS (JANUARY 2011–JULY 2022)59
TABLE 14LIST OF PATENTS IN ENDOLUMINAL SUTURING DEVICES MARKET,
2020–202259
6ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION61
6.1INTRODUCTION62
TABLE 15ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD MILLION)62
6.2BARIATRIC SURGERY62
6.2.1GROWING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH62
TABLE 16NUMBER OF BARIATRIC SURGERIES PERFORMED GLOBALLY (2018)63
TABLE 17US: NUMBER OF BARIATRIC SURGERIES, 2011–202064
TABLE 18ENDOLUMINAL SURGICAL DEVICES MARKET FOR BARIATRIC SURGERY,
BY COUNTRY, 2020–2027 (USD THOUSAND)64
6.3GASTROINTESTINAL SURGERY65
6.3.1GROWING BURDEN OF COLON CANCER TO INCREASE DEMAND FOR GASTROINTESTINAL SURGERY65
TABLE 19ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 202166
TABLE 20ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND)67
6.4GASTROESOPHAGEAL REFLUX DISEASE SURGERY67
6.4.1IMPROVING DIETS AND LIFESTYLE CHANGES TO RESTRAIN MARKET GROWTH67
TABLE 21ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE SURGERY, BY COUNTRY, 2020–2027 (USD THOUSAND)68
6.5OTHER SURGERIES68
TABLE 22ENDOLUMINAL SURGICAL DEVICES MARKET FOR OTHER SURGERIES,
BY COUNTRY, 2020–2027 (USD THOUSAND)69
7ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER70
7.1INTRODUCTION71
TABLE 23ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD MILLION)71
7.2HOSPITALS71
7.2.1GROWING NUMBER OF HOSPITALS WORLDWIDE TO PROPEL MARKET GROWTH71
TABLE 24NUMBER OF HOSPITALS, BY COUNTRY, 2010–202172
TABLE 25ENDOLUMINAL SUTURING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD THOUSAND)73
7.3CLINICS73
7.3.1QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS—
KEY ADVANTAGES DRIVING MARKET GROWTH73
TABLE 26ENDOLUMINAL SUTURING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD THOUSAND)74
7.4AMBULATORY SURGERY CENTERS74
7.4.1COST-EFFECTIVE TREATMENTS IN AMBULATORY CENTERS TO DRIVE DEMAND FOR THESE FACILITIES74
TABLE 27ENDOLUMINAL SUTURING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020–2027 (USD THOUSAND)75
7.5OTHER END USERS76
TABLE 28ENDOLUMINAL SUTURING DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD THOUSAND)77
8ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION78
8.1INTRODUCTION79
FIGURE 24ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2021)79
TABLE 29ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)80
8.2NORTH AMERICA80
TABLE 30NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)80
FIGURE 25NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT81
TABLE 31NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND)82
TABLE 32NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND)82
TABLE 33NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND)83
8.2.1US83
8.2.1.1US to dominate North American endoluminal suturing devices market during forecast period83
TABLE 34US: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)84
TABLE 35US: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND)84
TABLE 36US: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)85
8.2.2CANADA85
8.2.2.1Increasing volume of surgeries to fuel demand for endoluminal suturing devices in Canada85
TABLE 37CANADA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS,
AND FIVE-YEAR PREVALENCE (2020)86
TABLE 38CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)86
TABLE 39CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)86
8.3EUROPE87
TABLE 40EUROPE: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)87
TABLE 41EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY,
2020–2027 (USD THOUSAND)87
TABLE 42EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)88
TABLE 43EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)88
8.3.1GERMANY89
8.3.1.1High penetration of health insurance makes Germany largest market for endoluminal suturing devices in Europe89
TABLE 44GERMANY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)89
TABLE 45GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)90
TABLE 46GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND)90
8.3.2FRANCE91
8.3.2.1Well-established healthcare system and growing procedural volume boost market growth91
TABLE 47FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)91
TABLE 48FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)92
8.3.3UK92
8.3.3.1Growing volume of hernia repair and bowel cancer surgeries will stimulate market growth92
TABLE 49UK: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)92
TABLE 50UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND)93
TABLE 51UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)93
8.3.4ITALY94
8.3.4.1Initiatives to build awareness about digestive health to increase adoption of endoluminal suturing devices94
TABLE 52ITALY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)94
TABLE 53ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND)95
TABLE 54ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)95
8.3.5SPAIN95
8.3.5.1Growing healthcare budget to drive growth in Spain95
TABLE 55SPAIN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)96
TABLE 56SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)96
TABLE 57SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)97
8.3.6REST OF EUROPE97
TABLE 58REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND)98
TABLE 59REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND)98

8.4ASIA PACIFIC99
TABLE 60ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)99
FIGURE 26ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT100
TABLE 61ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD THOUSAND)101
TABLE 62ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)101
TABLE 63ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND)102
8.4.1JAPAN102
8.4.1.1Strong healthcare system in Japan supports growth of endoluminal suturing devices market102
TABLE 64JAPAN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)103
TABLE 65JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)103
TABLE 66JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)104
8.4.2CHINA104
8.4.2.1Growing number of hospitals and increased prevalence of obesity to propel growth in China104
TABLE 67CHINA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)105
TABLE 68CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD THOUSAND)105
TABLE 69CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)105
8.4.3INDIA106
8.4.3.1Increasing prevalence of gastrointestinal disorders and favorable government support to drive market in India106
TABLE 70INDIA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)106
TABLE 71INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION,
2020–2027 (USD THOUSAND)107
TABLE 72INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER,
2020–2027 (USD THOUSAND)107
8.4.4REST OF ASIA PACIFIC108
TABLE 73REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND)108
TABLE 74REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND)109
8.5LATIN AMERICA109
8.5.1GROWING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES TO PROPEL MARKET109
TABLE 75LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)110
TABLE 76BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)110
TABLE 77LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND)110
TABLE 78LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020–2027 (USD THOUSAND)111
8.6MIDDLE EAST & AFRICA111
8.6.1MIDDLE EAST & AFRICA—SMALLEST REGIONAL MARKET FOR ENDOLUMINAL SUTURING DEVICES111
TABLE 79MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020)111
TABLE 80MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY APPLICATION, 2020–2027 (USD THOUSAND)112
TABLE 81MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET,
BY END USER, 2020–2027 (USD THOUSAND)112
9COMPETITIVE LANDSCAPE113
9.1OVERVIEW113
9.2KEY PLAYER STRATEGIES/RIGHT TO WIN113
9.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS113
FIGURE 27REVENUE ANALYSIS OF KEY PLAYERS IN ENDOLUMINAL SUTURING DEVICES MARKET114
9.4MARKET SHARE ANALYSIS114
FIGURE 28ENDOLUMINAL SUTURING DEVICES MARKET SHARE, BY KEY PLAYER, 2021114
TABLE 82ENDOLUMINAL SUTURING DEVICES MARKET: DEGREE OF COMPETITION115
9.5COMPETITIVE BENCHMARKING116
TABLE 83ENDOLUMINAL SUTURING DEVICES MARKET: COMPETITIVE BENCHMARKING116
9.6COMPANY FOOTPRINT117
TABLE 84FOOTPRINT OF COMPANIES IN ENDOLUMINAL SUTURING DEVICES MARKET117
9.6.1APPLICATION FOOTPRINT117
TABLE 85APPLICATION FOOTPRINT OF COMPANIES117
9.6.2END-USER FOOTPRINT118
TABLE 86END-USER FOOTPRINT OF COMPANIES118
9.6.3REGIONAL FOOTPRINT118
TABLE 87REGIONAL FOOTPRINT OF COMPANIES118
9.7COMPANY EVALUATION QUADRANT119
9.7.1STARS119
9.7.2EMERGING LEADERS119
9.7.3PERVASIVE PLAYERS119
9.7.4PARTICIPANTS119
FIGURE 29ENDOLUMINAL SUTURING DEVICES MARKET: COMPANY EVALUATION QUADRANT (2021)120
9.8COMPETITIVE SCENARIO121
9.8.1PRODUCT LAUNCHES121
TABLE 88PRODUCT LAUNCHES (JANUARY 2019–JULY 2022)121
9.8.2OTHER DEVELOPMENTS121
TABLE 89OTHER DEVELOPMENTS (JANUARY 2019–JULY 2022)121
10COMPANY PROFILES122
10.1KEY PLAYERS122
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1APOLLO ENDOSURGERY, INC.122
TABLE 90APOLLO ENDOSURGERY, INC.: BUSINESS OVERVIEW122
FIGURE 30APOLLO ENDOSURGERY, INC.: COMPANY SNAPSHOT (2021)123
10.1.2JOHNSON & JOHNSON (ETHICON, INC.)125
TABLE 91JOHNSON & JOHNSON: BUSINESS OVERVIEW125
FIGURE 31JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)126
10.1.3MEDTRONIC PLC128
TABLE 92MEDTRONIC, INC.: BUSINESS OVERVIEW128
FIGURE 32MEDTRONIC PLC: COMPANY SNAPSHOT (2022)129
10.1.4COOK GROUP INCORPORATED131
TABLE 93COOK GROUP INCORPORATED: BUSINESS OVERVIEW131
10.1.5USGI MEDICAL133
TABLE 94USGI MEDICAL: BUSINESS OVERVIEW133
10.1.6OVESCO ENDOSCOPY AG135
TABLE 95OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW135
10.1.7ENDO TOOLS THERAPEUTICS S.A.136
TABLE 96ENDO TOOLS THERAPEUTICS S.A.: BUSINESS OVERVIEW136
10.1.8ERGOSUTURE137
TABLE 97ERGOSUTURE: BUSINESS OVERVIEW137
10.1.9SUTRUE LTD.138
TABLE 98SUTRUE LTD.: BUSINESS OVERVIEW138
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11APPENDIX139
11.1INSIGHTS FROM INDUSTRY EXPERTS139
11.2DISCUSSION GUIDE140
11.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL143
11.4CUSTOMIZATION OPTIONS145
11.5RELATED REPORTS145
11.6AUTHOR DETAILS146

Report Title: Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM